Methods of modulating T cell unresponsiveness

Details for Australian Patent Application No. 2006202939 (hide)

Owner Dana-Farber Cancer Institute

Inventors Nadler, Lee; Boussiotis, Vassiliki; Freeman, Gordon J.

Agent FB Rice

Pub. Number AU-B-2006202939

Parent 34379

Filing date 10 July 2006

Wipo publication date 3 August 2006

Acceptance publication date 20 November 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

27 July 2006 Complete Application Filed

3 August 2006 Application Open to Public Inspection

  Published as AU-B-2006202939

20 November 2008 Application Accepted

  Published as AU-B-2006202939

26 February 2009 Alteration of Name

  The name of the applicant has been altered to Dana-Farber Cancer Institute, Inc.

19 March 2009 Standard Patent Sealed

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006202940-TR3-specific binding agents and methods for their use

2006202938-Frequency Coherence within a Location Network